SEC Form 4 · accession 0001179110-17-012860

OMNICELL, INC. · OMCL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive V.P. CFO

Period of report

Oct 2, 2017

Accepted (ET)

Oct 2, 2017 · 7:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000926326

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F3,F1	Oct 2, 2017	S	3,000	$50.973	D	37,714	D
Common Stock^F3	Oct 2, 2017	M	3,362	$0.00	A	41,076	D
Common Stock^F3,F2	Oct 2, 2017	S	362	$50.90	D	40,714	D
Common Stock^F3,F2	Oct 2, 2017	S	170	$50.90	D	40,544	D
Common Stock	holding	—	—		—	40,714	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Option (right to buy)^F3	$32.78	Oct 2, 2017	M	3,000	A	Sep 1, 2016	Aug 31, 2025	Common Stock	3,000	3,000	D
Non-Qualified Option (right to buy)^F3	$27.70	Oct 2, 2017	M	362	A	Feb 4, 2017	Feb 3, 2026	Common Stock	362	362	D

F1The price reported in Column 4 is the average price of $50.9730. The shares sold between $50.80 to $51.15. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2The price reported in Column 4 is the exact price of $50.90. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.